Web Analytics

3 Latest Announced Rounds

  • $30,000,000
    Series B

    5 Investors

    Food and Beverage Services
    Nov 19th, 2024
  • $316,823
    Unknown

    1 Investors

    IT Services and IT Consulting
    Nov 19th, 2024
  • $7,200,000
    Seed

    1 Investors

    Software Development
    Nov 19th, 2024
$1,856.00M Raised in 85 Funding Rounds in the past 7 Days - View All

Funding Round Profile

3Daughters

start up
United States - Mansfield, MA
  • 23/01/2024
  • Unknown
  • $2,000,000

3Daughters is a clinical development company focused on Evolutionary Healthcare for Women. Our first evolution is a frameless, magnetic, nonhormonal intrauterine device (IUD) based on physics and geometry for long-acting contraception. Our unique IUD was designed to improve upon the outdated T-shape frame of current IUDs that causes pain, perforation and expulsion. These problems lead to a ‘fear factor’ for women and practitioners inserting the device. Current IUDs also require dangling strings for retrieval- a nuisance factor for women and their partners.

3Daughters newly designed IUD conforms naturally to a woman’s body and will address the 'fear factor', pain and other problems of current IUDs …with no strings attached! Nearly all women use contraception in their lifetimes, and we plan to make it better.


Related People

Mary Beth CiceroCo Founder

Mary Beth Cicero United States - Hull, Massachusetts

Seasoned pharmaceutical executive with over 35 years of experience in Business Development and Marketing. Partnering strategies (securing partners and/or products) and creative deal structuring are strong points. Also, skilled at assessing markets and identifying opportunities including designing and implementing market research. Like the challenge of identifying opportunities and developing innovative ways to capture revenue through funding, business development or commercial initiatives.
Academic background includes science, MBA and teaching as and Adjunct Professor at University of Miami Business School.